Telbivudine may prevent perinatal HBV transmission, study finds
Researchers found that none of the infants whose mothers received 600 milligrams of telbivudine daily from the 24th week through the 32nd week of gestation were hepatitis B virus-positive at 6 months, compared with 14.7% of those in the control group. The findings, published in Clinical Gastroenterology and Hepatology, also revealed no severe telbivudine-related adverse events or complications in the women or their infants. Specialty Pharmacy Times
Study links tubal ligation with improved endometrial cancer prognosis
A study in the Journal of the National Cancer Institute found that young women who had tubal ligation before developing aggressive endometrial cancer had increased survival rates compared with women who did not have tubal ligation. "Our study provides evidence that transtubal spread is an important mechanism of metastasis for aggressive histological types of endometrial carcinoma and that this process can be inhibited by TL," the study team wrote. MedPage Today (free registration)
Deadline tomorrow: NANN Conference Scholarship Program
Are you interested in attending NANN's 2015 Annual Educational Conference? NANN is pleased to offer scholarships to attend the 31st Annual Educational Conference taking place Oct. 22-25 in Dallas. Supported in part by a grant from Mead Johnson Nutrition, these scholarships are open to NANN members who have an interest in advancing their career and involvement in neonatal care, management and/or research. The deadline to apply is Friday, June 26. Learn more.
2015 NANN/NANNP Election
Make your voice heard in the 2015 NANN and NANNP election! NANN will elect one President-Elect, two Directors-at-large, and one Staff Nurse Director-at-large. NANNP will elect three Council Members. NANNP members will have access to NANN and NANNP ballots after logging in. Voting is underway and will close on Wednesday, July 15, at 11:59 pm PST. Vote now.
Please contact one of our specialists for advertising opportunities,
editorial inquiries, job placements, or any other questions.